Stem Cell Regenerative Medicine Conferences 2018 Zurich | Switzerland | USA | Europe

Theme: Frontiers in Stem Cells & Regeneration

Stem Cell Congress 2018

Scientific Program

Renowned Speakers

Hazem Barmada
Mississippi Stem Cell Treatment Center
USA

Brian M Mehling
Blue Horizon International LLC
USA

Michael Holte Heggeness
University of Kansas School of Medicine-Wichita
USA

Jane Lebkowski
Asterias Biotherapeutics
USA

Andrew Mearns Spragg
Jellagen Pty Ltd
UK

Janet Downie
Roslin Cell Therapies
UK

Denis Barritault
OTR3
France

Dennis M Lox
Sports and Regenerative Medicine Centers
USA

Verdon Taylor
University of Basel
Switzerland

SuEllen Pommier
Oregon Health & Science University
USA

Nilanjana Maulik
University of Connecticut Health Center
USA

Sasikanth Adigopula
Loma Linda University
USA

Wenzheng Zhang
Albany Medical College
USA

Raphael Gorodetsky
Hadassah-Hebrew University Medical Center
Israel

Guillermo Estivill Torrus
Biomedical Research Institute of Malaga
Spain

Haval Shirwan
University of Louisville
USA

Diana Anderson
University of Bradford
UK

Georg F Weber
University of Cincinnati Academic Health Center
USA

Thomas Bartosh
Texas A&M University Health Science Center
USA

Dean Nizetic
Nanyang Technological University
Singapore

Lucie Bacakova
Institute of Physiology of the Czech Academy of Sciences
Czech Republic

Stem Cell Congress 2018

Conference Series LLC LTD invites all the participants from all over the world to attend "10th Annual Conference on Stem Cell and Regenerative Medicine" during October 08-09, 2018 at Zurich, Switzerland which includes prompt keynote presentations, oral talks, poster presentations, networking, and exhibitions.

Stem cells are cells originate in all multi-cellular organisms. They were isolated in mice in 1981 and in humans in 1998. In humans, there are several types of stem cells, each with varying levels of potency. Stem cell treatments are a type of cell therapy that introduces new cells into adult bodies for possible treatment of cancer, diabetes, neurological disorders and other medical conditions. Stem cells have been used to repair tissue damaged by disease or age. Currently, it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. On the basis of geography, Europe holds the second place in the global market in the field of regenerative medicine & tissue engineering. In Europe countries like the UK, France and Germany are possessing good market shares in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe.

Objective

Stem Cell Congress-2018 has the goal to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Annual Conference on Stem Cell Congress 2018 will have an anticipated participation of 150+ delegates across the world to discuss the conference goal.

About Organizers

Conference Series LLC LTD is one of the leading Open Access publishers and organizers of international scientific conferences and events every year across the USA, Europe & Asia Conference Series LLC LTD has so far organized 300+ International Conferences across the World with 500+ peer-reviewed open access journals in basic science, health, and technology. Conference Series LLC LTD is also in association with more than 1000 International scientific and technological societies and associations and a team of 30,000 eminent scholars, reputed scientists as editorial board members.

Scientific Sessions

Stem Cell Congress-2018 will encompass recent researches and findings in stem cell technologies, stem cell therapies and transplantations, current understanding of cell plasticity in cancer and other advancements in stem cell research and cell science. Stem Cell Congress-2018 will be a great platform for research scientists and young researchers to share their current findings in this field of applied science. The major scientific sessions in Stem Cell Congress-2018 will focus on the latest and exciting innovations in prominent areas of stem cell and regenerative medicine research.

Conference Series LLC LTD invites all the participants from all over the world to attend 10th Annual Conference on Stem Cell and Regenerative Medicine during October 08-09, 2018 at Zurich, Switzerland which includes prompt keynote presentations, oral talks, poster presentations, networking, and exhibitions.

Track : Stem Cell

An undifferentiated cell of a multicellular creature which is fit for offering to ascend to inconclusively more cells of the same sort, and from which certain different sorts of cell emerge by separation. The most entrenched and generally utilized undifferentiated organism treatment is the transplantation of blood foundational microorganisms to treat infections and states of the blood and invulnerable framework or to restore the blood framework after medications for particular growths. Subsequent to the 1970s, skin undifferentiated organisms have been utilized to develop skin joins for patients with serious smolders on expansive territories of the body. Just a couple of clinical focuses can do this treatment and it is normally held for patients with life-debilitating blazes. It is likewise not a flawless arrangement: the new skin has no hair follicles or sweat organs. Research went into enhancing the strategy is continuous.

Related societies:

Europe: European Consortium for Stem Cell Research ; Cambridge Stem Cell Initiative ; Swiss Stem Cell Network ; The Scottish Stem Cell Network ; Danish Stem Cell Society ; European Society of Gene and Cell Therapy ; French Stem Cell Research Society ; Polish Society for Regenerative Medicine ; Spanish Society for Gene and Cell Therapy ; Irish Stem Cell Foundation ; Austrian Society for Stem Cell Research ; Austrian Society of Regenerative Medicine ; German Stem Cell Network.

USA: New York Stem Cell Foundation ; U.S. Stem Cell, Inc ; Stem Cell Clinical Trials ; International Society for Stem Cell Research ; Society for Hematology and Stem Cells ; Stem Cell Action Network ; Student Society for Stem Cell Research ; Tissue Engineering and Regenerative Medicine International Society ; International Society for Stem Cells Applications ; The Transplantation Society ; The American Society of Gene & Cell Therapy.

Asia Pacific and Middle East: Stem Cell Society Singapore ; Taiwan Society for Stem Cell Research ; The New South Wales Stem Cell Network ; Australian Society for Stem Cell Research ; Society for Tissue Engineering and Regenerative Medicine, India ; Korean Tissue Engineering and Regenerative Medicine Society ; Japanese Society for Regenerative Medicine ; Taiwan Association of ProloTherapy and Regenerative Medicine ; Stem Cell Society of India.

Track : Stem Cell Niche

A stem-cell niche is an area of a tissue that provides a specific microenvironment, in which stem cells are present in an undifferentiated and self-renewable state. Cells of the stem-cell niche interact with the stem cells to maintain them or promote their differentiation. The general niche model involves the association between resident stem cells and heterologous cell types—the niche cells.

CSHL Germ Cells Conference, USA, October 9-13, 2018 ; Conference on Regenerative Biology and Applications, Hong Kong, October 15-19, 2018 ; New York Stem Cell Foundation Conference, USA, October 23-24, 2018 ; Symposium on Translation of Stem Cells to the Clinic, Challenges and Opportunities, USA, December 02-04, 2018 ; From Stem Cells to Human Development Conference, UK, September 23-26, 2018 ; 6th Cambridge International Stem Cell Symposium, UK, September 19-21, 2018 ; Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, USA, August 19-24, 2018 ; Stem Cells in Disease Modelling and Drug Discovery, Australia, June 17-18, 2018 ; ISSCR 2018 Annual Meeting, Australia, June 20-23, 2018 ; Precision CRISPR Stem Cell Congress, USA, June 12-14, 2018 ; Conference on Hematopoietic Stem Cells: From the Embryo to the Aging Organism, Germany, June 07-09, 2018 ; Conference on Manufacturing and Testing of Pluripotent Stem Cells, USA, June 5-6, 2018 ; Cell & Gene Meeting, USA, October 3-5, 2018. Trends and Challenges in Regenerative Medicine and Cell Therapy, Germany, March 25–29, 2018 ; The Stem Cell Niche Conference, Denmark, May 27-31, 2018.

Related societies:

Europe: Belgian Society for Stem Cell Research ; UK Stem Cell Foundation ; International Stem Cell Forum ; British Society for Gene and Cell Therapy ; UK Regenerative Medicine Platform ; Austrian Society of Regenerative Medicine ; Scan Balt Stem Cell Research Network ; Student Society for Stem Cell Research ; Norwegian Center for Stem Cell Research ; Lund Stem Cell Center ; Stem Cell Network North Rhine-Westphalia ; UK Stem Cell Bank ; European Group for Blood and Marrow Transplantation ; Israel Stem Cell Society.

USA: Maryland Stem Cell Research Commission ; Harvard College Stem Cell Society ; International Society for Cellular Therapy ; California Institute for Regenerative Medicine ; American Society of Transplantation ; American Society for Matrix Biology ; American Society for Cell Biology ; National Stem Cell Foundation ; Perinatal Stem Cell Society ; International Placenta Stem Cell Society ; American Society for Blood and Marrow Transplantation ; Columbia University Stem Cell Initiative ; The American Regenerative Medicine Society.

Asia Pacific and Middle East: Hong Kong Stem Cell Society ; Chinese Society for Cell Biology ; Korean Society for Stem Cell Research ; Pakistan Stem Cell Society ; StemCell Thai Red Cross ; Iranian Stem Cell Council ; The Japanese Society for Regenerative Medicine ; Formosa Association Regenerative Medicine ; Iranian Society for Hematopoietic Stem Cell Transplantation ; International Society of Regenerative Medicine ; Japan Human Cell Society (Stem Cell).

Track : Induced Pluripotent Stem Cells

iPSC is derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. The discovery of induced pluripotent stem cells (iPSCs) has opened up unprecedented opportunities in the pharmaceutical industry, in the clinic, and in laboratories. In particular, the medical applications of human iPSCs in disease modeling and stem cell therapy have been progressing rapidly. The ability to induce cell fate conversion is attractive not only for these applications but also for basic research fields, such as development, cancer, epigenetics, and aging.

Related societies:

Track : Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells traditionally found in the bone marrow. However, mesenchymal stem cells can also be isolated from other tissues including cord blood, peripheral blood, fallopian tube, and fetal liver and lung. Multipotent stem cells, MSCs differentiate to form adipocytes, cartilage, bone, tendons, muscle, and skin. Mesenchymal stem cells are a distinct entity to the mesenchyme, embryonic connective tissue which is derived from the mesoderm and differentiates to form hematopoietic stem cells.

Related societies:

Track : Cancer Stem Cells

Cancer stem cells (CSCs) are cancer cells (found in tumors or hematological cancers) that possess characteristics associated with normal stem cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.

Related societies:

Track : Hematopoietic Stem Cells

Hematopoietic stem cells (HSCs) are multipotent, self-renewing progenitor cells that develop from mesodermal hemangioblast cells. All differentiated blood cells from the lymphoid and myeloid lineages arise from HSCs. HSCs can be found in the adult bone marrow, peripheral blood, and umbilical cord blood. More recent advances have resulted in the use of HSC transplants in the treatment of cancers and other immune system disorders.

Related societies:

Track : Embryonic Stem Cells

Embryonic Stem Cells are immortal cells having an almost unlimited developmental potential. These are made from cells found in very early human embryos, called blastocysts. Many scientists are working how to create specialized cell types found in the body by exposing Embryonic Stem Cells to different conditions which they can use to treat numerous different diseases, like multiple sclerosis, blindness, and diabetes.

Related societies:

Track : Adult Stem Cells

Adult stem cells are undifferentiated cells found throughout the body that divides to replenish dying cells and regenerate damaged tissues. Adult stem cell treatments have been used for many years to treat successfully leukemia and related bone/blood cancers through bone marrow transplants.

Scientific interest in adult stem cells is centered on their ability to divide or self-renew indefinitely, and generate all the cell types of the organ from which they originate, potentially regenerating the entire organ from a few cells.

Related societies:

Track : Stem Cell Therapy

Stem cell therapy is used to treat or prevent diseases by using stem cells. It has potential in a wide range of territories of potential and restorative examination. This treatment is by and large used to supplant or repair harmed cells or tissues. It additionally helps in transplanting immature microorganisms or giving medications those objective undifferentiated organisms as of now in the body. Undeveloped cell treatment is a rising innovation; the recovery of the body part is not really another idea.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Related societies:

Track : Stem Cell Transplantation

Stem cell transplantation, also referred to as bone marrow transplant, in which unhealthy blood-forming cells replace with healthy cells. Stem cell transplantation in combination with doses of chemotherapy or radiation therapy increases the chance of eliminating blood cancer in the marrow. Many researchers are working to improve stem cell transplantation procedures to make it an option for patients.arrangement: the new skin has no hair follicles or sweat organs. Research went into enhancing the method is progressing.

Related societies:

Track : Somatic Cell Therapy

Somatic cell treatment is the organization to people of autologous, allogeneic, or xenogeneic living cells which have been controlled or prepared ex vivo. Assembling of items for substantial cell treatment includes the ex vivo proliferation, development, choice. Substantial cell treatment is seen as a more moderate, more secure methodology since it influences just the focused on cells in the patient, and is not went on to future eras. Substantial quality treatment speaks to standard essential and clinical exploration, in which helpful DNA (either incorporated in the genome or as an outside episome or plasmid) is utilized to treat illness. Most concentrate on the extreme hereditary issue, including immunodeficiencies, hemophilia, thalassemia and cystic fibrosis. Such single quality issue is the great possibility for substantial cell treatment.

Related societies:

Track : Regenerative Medicine

Organ and tissue loss through disease and injury motivate the development of therapies that can regenerate tissues and decrease reliance on transplantations. Regenerative medicine, an interdisciplinary field that applies engineering and life science principles to promote regeneration, can potentially restore diseased and injured tissues and whole organs.

Related societies:

Track : Tissue Regeneration

Tissue Engineering is the investigation of the development of new connective tissues, or organs, from cells and a collagenous platform to create a completely useful organ for implantation over into the contributor host. Effective improvements in the multidisciplinary field of tissue building have created a novel arrangement of tissue new parts and execution approaches. Investigative advances in biomaterials, foundational microorganisms, development and separation components, and biomimetic situations have made special chances to manufacture tissues in the research facility from blends of designed extracellular networks cells and organically dynamic particles.

Related societies:

Track : Regeneration and Therapeutics

Tissue regeneration therapeutics, making foundational microorganisms for supportive application in regenerative pharmaceutical. A regenerative solution is to offer the body some help with recuperating itself more sufficiently. It also develops OsteoScaf, a biodegradable, fully resorbable, and osteoconductive scaffold for use in healing tissue defects. In regenerative pharmaceutical, cell, tissue and organ substitutes are made to restore normal limit that has been lost.

Related societies:

Track : Stem Cell Apoptosis and Signal Transduction

Self-replication and proliferation of stem cell populations are controlled, by induction of apoptosis. The number of stem cells is, therefore, a balance between those lost to differentiation/apoptosis and those gained through proliferation. Apoptosis of stem cells is believed to be a dynamic process which changes in response to environmental conditions. For example, the release of stem cell factor inhibits apoptosis following spinal cord injury, presumably in an attempt to promote tissue repair. Dysregulation of apoptosis in stem cells is believed to underlie some cancer pathologies, where apoptotic resistance results in uncontrolled growth (i.e. glioblastoma). Controlling apoptosis is also an important focus for studies of stem cell transplantation, where inhibition may increase the survival of grafted cells during replacement therapy. Harnessing the full therapeutic potential of stem cells will require full elucidation of the signal transduction cascades for proliferation, differentiation, and apoptosis.

Related societies:

Track : Immunological Challenges for Stem Cells

Stem cells have a huge potential for treating disease but one challenging area is that involving a patient's immune system. Also, the increasing numbers of stem cell therapies are entering clinical trials and the issue of the immunological consequences are also unusual and it's important to understand what exactly happens during immune rejection before looking at the different immunological consequences from the use of embryonic stem cells.

Related societies:

Track: Computational Stem Cell Biology & Systems Biology

Computational Biology sometimes referred to as bioinformatics, is the science of using biological data to develop algorithms and relations among various biological systems. Bioinformatics groups use computational methods to explore the molecular mechanisms underpinning stem cells. To accomplish this bioinformatics develop and apply advanced analysis techniques that make it possible to dissect complex collections of data from a wide range of technologies and sources.

Related societies:

Track : Novel Stem Cell Technologies

Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians and offers hope of effective stem cell treatment for a variety of malignant and non-malignant diseases. Stem cells are defined as totipotent progenitor cells capable of self-renewal and multilineage differentiation. Most development is in developing cell culture media, cell separation products, instruments and other reagents for use in stem cell immunology, cancer, regenerative medicine and cellular therapy research.

Related societies:

Track : Stem Cell BioBanking & Tissue Preservation

Stem cell banking through long-term storage of different stem cell platforms represents a fundamental source to preserve original features of stem cells for patient-specific clinical applications. Stem cell research and clinical translation constitute fundamental and indivisible modules catalyzed through biobanking activity, generating a return of investment.

Related societies:

Track : Biomaterials & Stem Cells

Biomaterials and stem cell has the potential for the treatment of diseases to the repair and regeneration of the organs. Modern stem cells in regenerative medicine are mainly using three-dimensional structured biomaterials in combination with stem cells as a cell source. Biomaterial scaffolds are developed that not only serve as cell carriers providing mechanical support, but actively influence cellular responses including cell attachment and proliferation. Researchers are working in the field of identification of biomaterials which is most suitable for stem cells in regenerative medicine.

Related societies:

Track : 3D Bioprinting & Biofabrication

3D Bioprinting aids stem cells in tissue engineering by providing an in-depth information of the image and structure analysis of the image. Biofabrication is referred to the production of artificial tissues or organs to address health challenges in medicine. It often uses the principle of 3D Bioprinting to form cells, gels, and fibers into an organ.

Related societies:

Market Analysis Report:

Stem cell & Regenerative Medicine is an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ. Regenerative medicine is not one discipline. It can be defined as a therapeutic intervention which “replaces or regenerates human cells, tissues or organs, to restore or establish normal function” and deploys small molecule drugs, biologics, medical devices and cell-based therapies.

Currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole.The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. On the basis of geography, Europe holds the second place in the global market in the field of regenerative medicine & tissue engineering. In Europe countries like UK, France and Germany are possessing good market shares in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe.

Stem Cell Market Value:

Worldwide many companies are developing and marketing specialized cell culture media, cell separation products, instruments and other reagents for life sciences research. We are providing a unique platform for the discussions between academia and business.

Global Tissue Engineering & Cell Therapy Market, By Region, 2009 2018

$Million

Major Stem Cell Organization Worldwide:

· Norwegian Center for Stem Cell Research

· France I-stem

· Stem Cell & Regenerative Medicine Ctr, Beijing

· Stem Cell Research Centre, Korea

· NSW Stem Cell Network

· Monash University of Stem Cell Labs

· Australian Stem Cell Centre

Target Audience:

Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations heads and Professors, Research scientists, Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Stem cell research, stem cell line companies can be as Target Audience

Market Analysis of Stem Cell Therapy:

The global market for stem cell products was $3.8 billion in 2011. This market is expected to reach nearly $4.3 billion in 2012 and $6.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11.7% from 2011 to 2016.

Americas is the largest region of global stem cell market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018

Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013.

Figure 2: Global Market

Companies working for Stem Cells:

Company	Location	Business Type
Cynata Therapeutics	Armadale, Australia	Stem Cell Manufacturing Technology
Mesoblast	Melbourne, Australia	Regenerative Medicine
Activartis	Vienna, Austria	Dendritic Cell-Based Cancer Immunotherapy
Aposcience	Vienna, Austria	Treatments composed of mixture of cytokines, growth factors and other active components
Cardio3 Biosciences	Mont-Saint-Guibert, Belgium	Stem Cell Differentiation
Orthocyte (BioTime)	Alameda, CA	Cellular Therapies
Capricor	Beverly Hills, CA	Stem Cell Heart Treatments
Life Stem Genetics	Beverly Hills, CA	Autologous stem cell therapy
International Stem Cell	Carlsbad, CA	Proprietary Stem Cell Induction
Targazyme	Carlsbad, CA	Cell Therapy
DaVinci Biosciences	Costa Mesa, CA	Cellular Therapies
Invitrx Therapeutics	Irvine, CA	Autologous Stem Cell Therapy, Therapeutic & Cosmetic

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	October 08-09, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View

10th Annual Conference on Stem Cell and Regenerative Medicine October 08-09, 2018 Hilton Zurich Airport, Zurich, Switzerland

Recommended Global Genetics & Molecular Biology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Stem Cell Congress 2018

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues